The Latest in Oncology Practice

ASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTE

November 26, 2019

Combo elicits lasting responses in metastatic melanoma

November 25, 2019

Atezolizumab/bevacizumab may offer benefit to patients with RCC

November 25, 2019

Survey: Cancer-related pain, opioid use up since 2018

November 25, 2019

FDA approves acalabrutinib for CLL, SLL treatment

November 21, 2019

Leukemia, Myelodysplasia, Transplantation

Open enrollment 2020: Activity down on Healthcare.gov

November 21, 2019

Practice Management

FDA approves Givlaari for treatment of acute hepatic porphyria

November 21, 2019

Rare Diseases

Vaping front and center at Hahn’s first FDA confirmation hearing

November 20, 2019

Practice Management

Multimodal therapies almost double survival in anaplastic thyroid cancer

November 20, 2019

Head & Neck/Thyroid Cancers

Melanoma incidence drops in younger age groups

November 20, 2019

Melanoma

Frontline ibrutinib saves money over chemoimmunotherapy

November 20, 2019

Practice Management

Early lenalidomide may delay progression of smoldering myeloma

November 19, 2019

Lymphoma & Plasma Cell Disorders

Not all lung cancer patients receive treatment

November 19, 2019

Lung Cancer

Rituximab maintenance has a durable benefit in follicular lymphoma

November 19, 2019

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019